Acellera Therapeutics Inc.
Drug discovery company leveraging AI, quantum chemistry, and molecular simulations to accelerate small molecule discovery.
Where Acellera Therapeutics Inc. ranks
Current edition · updated Oct 20, 2026About Acellera Therapeutics Inc.
Drug discovery company leveraging AI, quantum chemistry, and molecular simulations to accelerate small molecule discovery.
Products
Software framework for molecular dynamics-based discovery and the first biomolecular simulation code to run on GPUs.
Integrated discovery platform for small molecules featuring generative AI, machine learning, quantum mechanics, molecular simulations, and GPU computing.
AI and simulations platform and drug design environment for AI agents, hosted on Acellera's computing infrastructure.
Virtual screening and docking software utilizing KDEEP for pose re-scoring, supporting free, ensemble, constrained, and template docking.
Reinforcement learning toolkit for generative drug design, utilizing chemical language models to generate virtual compound libraries while optimizing multiple objectives.
Service utilizing molecular dynamics to reconstruct the entire binding process of a ligand to its target, capturing induced-fit effects, water networks, and cryptic pocket opening.
Molecular dynamics service for studying protein flexibility and mapping the conformational landscape of targets using HTMD adaptive sampling protocols.
Service partnering with CROs to provide experimentally validated molecules via biochemical and cell-based assays, comparing computational predictions with real-world data.
End-to-end drug discovery partnership services leveraging the QuantumBind platform to go from target to a prioritized list of leads, including generative AI, binding free energy...
Security and compliance
As reported by Acellera Therapeutics Inc.. Ask for audit reports before you buy.
- ISO/IEC 27001In progress
- Information Security Management System (ISMS) aligned with ISO 27001
- Confidentiality controls preventing unauthorized disclosure and access
- Integrity controls ensuring accuracy and preventing deterioration of customer information
- Availability controls ensuring access to customer information across all media
- Annual information security objectives
- Risk analysis, management, and treatment process for information assets
- Control objectives and controls to mitigate identified risks
- Security breach reporting by employees
- Information security training and awareness for all personnel
- Strict security procedures for storage and disclosure of personal data
- Third-party security requirements aligned with Spanish and EU data protection rules
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim Acellera Therapeutics Inc.